Cingulate Inc (CING)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $62.53M
Last updated: Nov 17, 2026 at 11:05 AM ET
Cingulate Inc (CING) Earnings: Report Dates and Results
In the quarter ended Sep 30, 2026, Cingulate reported EPS of -$0.53, below the -$0.48 estimate. It beat the EPS estimate in 2 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
CING's report for the quarter ending Dec 31, 2026 is not on the earnings calendar yet.
Earnings History
Of the 20 quarters below that had an estimate, CING beat 8 and missed 12. The widest gap in the table came in the quarter ended Mar 31, 2022, when EPS landed 87.23% below the estimate.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported |
|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | -$0.53 | -$0.48 | -$0.55 - -$0.39 | -10.42% | Miss | N/A | 3 | 2 up, 1 down | Nov 13, 2026 |
| Jun 30, 2026 | -$0.45 | -$0.63 | -$0.77 - -$0.33 | +28.57% | Beat | N/A | 3 | 1 up, 1 down | Aug 13, 2026 |
| Mar 31, 2026 | -$0.95 | -$0.53 | -$0.74 - -$0.38 | -79.25% | Miss | N/A | 3 | 3 up, 0 down | May 14, 2026 |
| Dec 31, 2025 | -$0.84 | -$1.55 | -$4.32 - -$0.38 | +45.81% | Beat | N/A | 4 | 1 up, 2 down | Mar 18, 2026 |
| Sep 30, 2025 | -$1.35 | -$0.75 | -$0.96 - -$0.53 | -80.00% | Miss | N/A | 5 | 1 up, 2 down | Nov 13, 2025 |
| Jun 30, 2025 | -$1.09 | -$0.82 | -$0.90 - -$0.62 | -32.93% | Miss | N/A | 4 | 0 up, 1 down | Aug 19, 2025 |
| Mar 31, 2025 | -$1.04 | -$0.98 | -$1.00 - -$0.96 | -6.12% | Miss | N/A | 2 | 1 up, 0 down | May 8, 2025 |
| Dec 31, 2024 | -$3.68 | -$2.93 | N/A | -25.60% | Miss | N/A | 3 | 1 up, 0 down | Mar 27, 2025 |
| Sep 30, 2024 | -$1.83 | -$2.22 | -$3.03 - -$1.41 | +17.57% | Beat | N/A | 3 | 0 up, 0 down | Nov 7, 2024 |
| Jun 30, 2024 | -$5.47 | -$4.92 | -$6.36 - -$4.92 | -11.18% | Miss | N/A | 2 | 0 up, 0 down | Aug 13, 2024 |
| Mar 31, 2024 | -$19.20 | -$52.72 | N/A | +63.58% | Beat | N/A | 2 | 1 up, 0 down | May 8, 2024 |
| Dec 31, 2023 | -$7.66 | -$4.86 | -$6.26 - -$2.60 | -57.61% | Miss | N/A | 4 | 0 up, 0 down | Mar 29, 2024 |
| Sep 30, 2023 | -$72.00 | -$90.40 | -$117.65 - -$57.62 | +20.35% | Beat | N/A | 4 | 0 up, 0 down | Nov 13, 2023 |
| Jun 30, 2023 | -$136.80 | -$81.60 | -$91.24 - -$72.03 | -67.65% | Miss | N/A | 3 | 0 up, 0 down | Aug 14, 2023 |
| Mar 31, 2023 | -$84.00 | -$77.60 | -$110.44 - -$57.62 | -8.25% | Miss | N/A | 4 | 0 up, 0 down | May 10, 2023 |
| Dec 31, 2022 | -$0.41 | -$0.37 | -$0.45 - -$0.25 | -10.81% | Miss | N/A | 4 | 0 up, 0 down | Mar 10, 2023 |
| Sep 30, 2022 | -$86.40 | -$88.80 | -$91.24 - -$86.43 | +2.70% | Beat | N/A | 2 | 0 up, 0 down | Nov 14, 2022 |
| Jun 30, 2022 | -$86.40 | -$139.20 | N/A | +37.93% | Beat | N/A | 1 | 0 up, 0 down | Aug 11, 2022 |
| Mar 31, 2022 | -$105.60 | -$56.40 | -$57.62 - -$55.22 | -87.23% | Miss | N/A | 2 | 0 up, 0 down | May 12, 2022 |
| Dec 31, 2021 | -$0.32 | -$0.39 | -$0.39 - -$0.39 | +17.95% | Beat | N/A | 1 | 0 up, 0 down | Mar 10, 2022 |
| Sep 30, 2021 | -$1.38 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Dec 9, 2021 |
| Jun 30, 2021 | -$0.35 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Sep 27, 2021 |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was -$4.32, after -$30.18 the year before. It was -$2.05 for the year ended Dec 31, 2021, the oldest of the 5 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | -$4.32 | N/A |
| Dec 31, 2024 | -$30.18 | N/A |
| Dec 31, 2023 | -$300.46 | N/A |
| Dec 31, 2022 | -$278.81 | N/A |
| Dec 31, 2021 | -$2.05 | N/A |
Frequently Asked Questions About CING
Did CING beat earnings estimates last quarter?
No. Cingulate reported EPS of -$0.53 for the quarter ended Sep 30, 2026, below the -$0.48 estimate by 10.42%.
What EPS do analysts expect from CING next quarter?
The consensus EPS estimate for Cingulate for the quarter ending Dec 31, 2026 is -$0.35 from 8 analysts, with estimates from -$0.58 to $0.05.
How often does CING beat earnings estimates?
Cingulate beat the EPS estimate in 2 of the last 8 quarters, with an average surprise of -19.99%.
CING pages: Overview, Earnings, Forecast, Financials, Competitors